
Opinion|Videos|June 11, 2024
Exploring the First FDA-Approved Treatment to Delay T1D Onset: Mechanism of Action and Treatment Impact
Diabetes specialists from UCSD discuss teplizumab, the first FDA-approved drug for delaying onset of T1D, highlighting its benefits and mechanism of action.
Advertisement
Episodes in this series

Advertisement
Advertisement
Advertisement
Trending on Patient Care Online
1
Semaglutide Reduces BMI by 13.5% in Children Aged 6-11 in Step Young Trial
2
Sequential NITs Rule Out Advanced Fibrosis in Primary Care
3
Making Liver Fibrosis Testing Routine, With Zobair Younossi, MD, MPH
4
FDA Approves Dexmedetomidine as First At-Home Treatment for Acute Agitation
5




